These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 626968)

  • 1. A potent inhibitor of normal and transformed cell growth derived from contact-inhibited cells.
    Lipkin G; Knecht ME; Rosenberg M
    Cancer Res; 1978 Mar; 38(3):635-43. PubMed ID: 626968
    [No Abstract]   [Full Text] [Related]  

  • 2. [Restoration of growth contact inhibition in malignant melanocytes from man, mice, and hamsters].
    Lipkin G; Knecht ME
    Schweiz Med Wochenschr; 1975 Oct; 105(42):1360-4. PubMed ID: 1226513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a bacteriocin produced by Mycobacterium smegmatis on growth of cultured tumor and normal cells.
    Saito H; Watanabe T
    Cancer Res; 1979 Dec; 39(12):5114-7. PubMed ID: 498138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro and in vivo investigation of three surface-active agents as modulators of cell proliferation.
    Tobler J; Watts MT; Fu JJ
    Cancer Res; 1980 Apr; 40(4):1173-80. PubMed ID: 7357547
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of uncontrolled nuclear division in somatic cell hybrids of normal and transformed cells.
    O'Neill FJ
    J Natl Cancer Inst; 1980 Sep; 65(3):497-506. PubMed ID: 6931930
    [No Abstract]   [Full Text] [Related]  

  • 6. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
    Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the growth characteristics of mouse and rat fibroblasts during tumor progression].
    Lavrovskiĭ VA; Dobrunova EP; Shcherbakov AE
    Eksp Onkol; 1989; 11(3):43-6. PubMed ID: 2752942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of cell growth behavior in vitro to tumorigenicity in athymic nude mice.
    Stiles CD; Desmond W; Chuman LM; Sato G; Saier MH
    Cancer Res; 1976 Sep; 36(9 pt.1):3300-5. PubMed ID: 975091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors intervening in the variability of the antitumoral activity of thymus extracts].
    Potop I; Holban-Petrescu R; Ghinea E; Mreană G; Juvină E
    Stud Cercet Endocrinol; 1972; 23(1):29-32. PubMed ID: 5063193
    [No Abstract]   [Full Text] [Related]  

  • 12. Concanavalin A-induced agglutination and tumorigenicity in virally and spontaneously transformed cells derived from BALB-c mice.
    Van Nest GA; Grimes WJ
    Cancer Res; 1974 Jun; 34(6):1408-12. PubMed ID: 4363657
    [No Abstract]   [Full Text] [Related]  

  • 13. A survey of intracellular Na+ and K+ of various normal, transformed, and tumor cells.
    Moyer MP; Moyer RC; Waite MR
    J Cell Physiol; 1982 Oct; 113(1):129-33. PubMed ID: 7130286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
    Panet R; Marcus M; Atlan H
    J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cell division in the malignant transformation of mouse cells treated with 3-methylcholanthrene.
    Kakunaga T
    Cancer Res; 1975 Jul; 35(7):1637-42. PubMed ID: 1169110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on antagonistic actions of TPA and retinoic acid.
    Jetten AM; De Luca LM
    Carcinog Compr Surv; 1982; 7():513-8. PubMed ID: 6978181
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and characterization of revertant cell lines. 3. Isolation of density-revertants of SV40-transformed 3T3 cells using colchicine.
    Vogel A; Risser R; Pollack R
    J Cell Physiol; 1973 Oct; 82(2):181-8. PubMed ID: 4356675
    [No Abstract]   [Full Text] [Related]  

  • 19. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
    Bertram JS; Faletto MB
    Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
    Bordoni R; Fine R; Murray D; Richmond A
    J Cell Biochem; 1990 Dec; 44(4):207-19. PubMed ID: 2095366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.